BENCHMARK PROFILE
NovaForge Labs
Latest sync: Sep 18, 2026, 9:33 PM. Source coverage currently reflects PB Evidence data.
Readers who want public prices, mix-and-match bundle math, retained lot history, and laboratory-verifiable reports from both Freedom Diagnostics and ILS.
Vendor-stated: NovaForge Labs / NoeSol Group LLC, mailing address 1812 W Burbank Blvd. PMB #642, Burbank, CA 91506; [email protected]. U.S.-only shipping is $6.95 below $200 and free at $200 or more; confirmed weekday orders before 1 PM Pacific are stated to ship the same business day. Local pickup may be arranged. Observed September 18, 2026.
KPV 10mg is the one current research offer without a public certificate in the registry. One historical BPC-157 / TB-500 report is for 80mg despite being filed under the current 20mg product, so it is retained without credit to that live strength; a separate Tesamorelin 20mg report is corrected from the registry’s 10mg product id. The blanket storefront fentanyl-screen claim is not inherited onto Freedom reports that do not print that panel. NOVA15, BACK15, referral credit, rewards, and the open affiliate program are captured context, not PeptideBenchmark discounts.
A Burbank-mailed research storefront with public single-vial pricing, a mixed-or-repeated bundle builder, and a public certificate registry whose Freedom Diagnostics and ILS Laboratories documents resolve to exact laboratory records.
NovaForge Labs publishes a compact research catalog with live prices and stock state, including house labels Dual-Agonist and Triple-Agonist that laboratory documents identify as tirzepatide and retatrutide. PeptideBenchmark tracks comparable single-vial offers, models the public three- and five-item builder separately, routes nasal sprays to the non-vial inventory, and keeps first-order, returning-customer, referral, rewards, and public affiliate-program offers outside default ranked prices.
The public COA registry retains current and prior Freedom Diagnostics and ILS Laboratories reports. Each credited document resolves at the issuing laboratory under the NovaForge Labs client identity and matches the vendor copy byte for byte. Two early Freedom reports print the narrow clerical typo NovsForge Labs; PeptideBenchmark accepts only that exact reviewed alias. Published reports support identity, HPLC purity, and net content for the named samples; panel credit stays document-specific. ILS has current ISO/IEC 17025 accreditation, but its published scope covers cannabis/hemp testing rather than peptide analysis.
This vendor is one of 119 names currently included in our manual curated research-vendor layer.
This is the strongest public transparency pattern on the site. The key signal is that readers can leave the vendor domain and inspect reports or verification pages on an outside provider domain without needing to log in.
- Treat the outside provider route as the strongest part of the evidence, not the vendor marketing copy around it.
- Look for repeated product-level behavior across the catalog, not just one showcase example.
- Do not overread it as proof that every current lot is covered or current unless the linked report trail itself supports that.
This vendor makes the most sense when you compare it to other vendors using a similar transparency model, rather than to every vendor on the board at once.
PB Curated Assessment is a PeptideBenchmark-authored rubric built from the trust and transparency review layer. It is separate from the source-derived benchmark score.
NovaForge Labs is currently one of the strongest curated cases on the site because readers can inspect a repeatable public evidence trail without logging in.
Readers can leave the vendor marketing layer and inspect verification publicly.
This is the strongest public pattern because the verification step routes into an outside provider layer.
Current review touched 17 products and 27 document/link destinations.
2 named lab signal(s) and 1 certification category signal(s) are currently visible in the reviewed evidence.
Score 7.6 from pb evidence score.
PB Curated Assessment: Strong. This is our own trust/transparency rubric and is kept separate from the PB score.
Under the formula retired on Aug 28, 2026 this vendor scores 7.75 — the live evidence-first score is 8.61 (+0.86). What changed and why: scoring methodology.
Assayed content is not fill accuracy. Laboratories report net peptide content, and peptides ship as salts, so an honestly filled vial commonly assays below its gross label — a figure under 100% is not evidence of a short vial. These numbers are also not comparable between vendors: they exist only where a laboratory reports net content, so they partly reflect which laboratory a vendor uses.
Holding a certificate for this vendor that is not here?Send it to the archive →
Same third-party review signals shown on the vendor board. Click Trustpilot or Pep Review Pro to open the source profile.
PB score is the number you should read first on this page. It starts with trust evidence, pricing coverage, and third-party review signals from Finnrick, Peptide Critic, Trustpilot, and Pep Review Pro when available. Reviewed transparency evidence contributes a bounded amount — shown as a trust lift for source-benchmarked vendors, and folded into the base score for PB-evidence vendors.
This vendor’s score is evidence-first: verifiable testing evidence forms the backbone, and outside review sources are a bounded adjustment that can warn far more than it can boost. The terms below sum to the displayed score (small rounding aside). Full formula on the scoring methodology page.
WHAT THIS PAGE IS
- Board-ranked vendor profile with source-linked benchmark inputs
- No Finnrick score currently linked
- No Peptide Critic score currently linked
- No Trustpilot profile currently linked
- No Pep Review Pro profile currently linked
CURRENT LIMITS
- Not an original lab test or editorial review
- Source scales and methodologies differ across sites
- Depends on source site freshness and formatting
These are representative public examples from the vendor testing review queue. They show how product pages in the catalog expose public report or verification paths, but they should still be read as examples rather than proof for every current lot.
In other words: the relationship registry above captures the vendor-to-provider link itself, while the examples below show what that link looks like across real product pages.
METHODOLOGY
How to read this benchmark
This profile summarizes public benchmark data synced from Finnrick and, when available, Peptide Critic. Finnrick contributes a 10-point average from its vendor table, while Peptide Critic contributes a 5-star rating that we normalize to a 10-point scale before ranking consensus entries.
A high score can be directionally useful, but it is not a substitute for current COAs, identity testing, chain-of-custody details, or your own due diligence. We are intentionally separating source aggregation from first-party editorial claims.
Scores combine PB trust evidence with external signals from Finnrick, Peptide Critic, Trustpilot, and Pep Review Pro when available.